First AI-generated drug enters human clinical trials, targeting chronic lung disease patients

2 years ago 19

The first drug ever generated by artificial intelligence has entered Phase 2 clinical trials with lung disease patients; the first dose was successfully administered to a human, Insilico Medicine announced.

1. Homepage
2. National News
3. First AI-generated drug enters human clinical trials, targeting chronic lung disease patients